Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice

  • Mark Mooney
  • , Y.H.A. Abdel-Wahab
  • , L.M. Morgan
  • , F.P.M. O'Harte
  • , P.R. Flatt

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Gastric inhibitory polypeptide (GIP) is produced within endocrine cells of the small intestine and released into the circulation upon nutrient ingestion. This study has quantified the levels of this insulinotropic peptide in the intestines of lean and diabetic obese ob/ob mice and estimated the proportion that is glycated. The total intestinal GIP concentration and content of the diabetic mice were significantly greater (p
Original languageEnglish
Pages (from-to)167-171
Number of pages5
JournalEndocrine
Volume16
Issue number3
Publication statusPublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Endocrinology

Fingerprint

Dive into the research topics of 'Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice'. Together they form a unique fingerprint.

Cite this